NCT05712694 2026-04-20
Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)
Polaris Group
Phase 3 Recruiting
Polaris Group
PharmaMar
European Organisation for Research and Treatment of Cancer - EORTC
Advenchen Laboratories, LLC